ARCHIMEDES Compassionate Use Supplement
NCT00660556 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2020-11-06
Summary
The purpose of this Compassionate Use Supplement to the IDE Protocol is to assure and monitor the safety of six Subjects (in the United States) implanted with ARCHIMEDES until all remaining implanted pumps are explanted.
Conditions
Interventions
- DEVICE
-
Archimedes Constant Flow Pump & System
Pump implanted in abdomen with intrathecal delivery (catheter) for pain.
Sponsors & Collaborators
-
Cerenovus, Part of DePuy Synthes Products, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Maintaining Patency in Implanted Port Catheters
NCT02354118 ·Status: COMPLETED ·Phase: NA
-
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)
NCT07095660 ·Status: RECRUITING ·Phase: NA
-
Distal vs Conventional Transradial Access for Coronary Procedures
NCT07138170 ·Status: COMPLETED ·Phase: NA
-
CompuFlo Thoracic Epidural Study
NCT03826186 ·Status: COMPLETED ·Phase: NA
-
AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)
NCT03573206 ·Status: COMPLETED ·Phase: NA
-
Assessment of CymActive™ Catheter Technology for UrinAry ReTention and AcceptancE (The ACCTUATE Study)
NCT05848037 ·Status: TERMINATED ·Phase: NA
-
Assess Veinplicity Venous Access Device Safety and Effectiveness
NCT03109405 ·Status: COMPLETED ·Phase: NA
-
Using the Accuvein Device for Patients Who Are Difficult to Perfuse
NCT06861595 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes
NCT02923830 ·Status: TERMINATED ·Phase: PHASE4
-
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)
NCT07219758 ·Status: RECRUITING ·Phase: NA
-
Emergency/Compassionate Use PFO Occluder
NCT00584064 ·Status: APPROVED_FOR_MARKETING
-
Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System
NCT03756558 ·Status: COMPLETED ·Phase: NA
-
Taurolidine Containing Antimicrobial CIED Wash to Prevent Infection
NCT05576194 ·Status: COMPLETED
-
A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval Filter System
NCT02674672 ·Status: COMPLETED ·Phase: NA
-
Continuous Adductor Canal Block With a New Catheter - Primary Placement and Secondary Repositioning
NCT02657603 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Catheter Reminder and Evaluation Program
NCT01797146 ·Status: COMPLETED ·Phase: NA
-
The Safety and Efficacy of the Suture-Mediated Closure System
NCT05841836 ·Status: UNKNOWN ·Phase: NA
-
Clinical Pharmacy for Patients with a PICC Line
NCT04359056 ·Status: COMPLETED ·Phase: NA
-
Clinical Study Evaluating Use of the CapBuster Medical Device System for the Crossing of Chronic Total Occlusions
NCT04710342 ·Status: UNKNOWN ·Phase: NA
-
Effect of CAUTI Prevention Alert - A Randomized Control Trial
NCT02054065 ·Status: COMPLETED ·Phase: NA
-
Investigation of New Intermittent Catheter Swelling Media in Healthy Volunteers
NCT04633291 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9%
NCT01826526 ·Status: COMPLETED ·Phase: NA
-
The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain
NCT02746419 ·Status: WITHDRAWN ·Phase: NA
-
Delphi Study to Identify Crucial Steps and Errors in the Placement of Chest Tubes
NCT05623631 ·Status: COMPLETED ·Phase: NA
-
The Performance / Safety of the Celsite® Venous Access Ports
NCT05572112 ·Status: UNKNOWN